A new cannabis study published in the New England Journal of Medicine saw a nearly 40 percent drop in seizures for participants who were using the marijuana derivative called cannabidiol.
Tag Archives: New England Journal of Medicine
GW Pharma to File Cannabis Drug as Epilepsy Success Confirmed
GW Pharmaceuticals is set to file its cannabis-derived drug with U.S. regulators imminently, following publication of detailed data on its success in fighting severe childhood epilepsy.
Cannabis Derivative Cannabidiol Reduces Seizures in Severe Epilepsy Disorder
NEW YORK, May 24, 2017 /Weed Wire/ – After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency 39 percent for patients with Dravet syndrome—a rare, severe form of epilepsy—in the first large-scale, randomized clinical trial for the compound.